About Company
- Legal Name: SHANDONG LUKANG PHARMACEUTICAL CO., LTD.
- International Name: 山东鲁抗医药股份有限公司 (Shandong Lukang Pharmaceutical Co., Ltd.), Jining, Shandong
- Brand / Trade Name: Lukang
- Registered country: China
- Address: 88 Deyuan Road, High-Tech Zone, Jining city • Shandong
- Number of employees: From 5000
Description:
Established in 1966, Shandong Lukang Pharmaceutical Co., Ltd. is a large-scale, state-owned biopharmaceutical enterprise specializing in R&D, manufacturing and marketing APIs and finished dosage forms for human, veterinary and agricultural use. Its main products include Spectinomycin HCl/Sulfate (CEP and FDA approved), Tylosin Tartrate (CEP and FDA approved), Flunixin Meglumine (CEP approved), Tylosin Base (CEP pending), Tilmicosin Base/Phosphate, Tulathromycin, Tiamulin Fumarate, Ceftiofur Sodium/HCl, Ceftriaxone Sodium and Cefazolin Sodium.
Business Activities
Veterinary Pharmaceuticals & Feed Additives
Manufacturer
Finished Dosage Forms
API ManufacturerMarketing Authorization HolderManufacturer
Active Pharmaceutical Ingredients (APIs)
Manufacturer
Packaging Materials
Manufacturer
Biopharmaceutical Products
Manufacturer
Innovator APIs
Manufacturer
Contract & Outsourcing Services
Manufacturer
Sales Markets
- Northern Europe: Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, United Kingdom
- Southern Europe: Albania, Andorra, Bosnia and Herzegovina, Croatia, Greece, Italy, North Macedonia, Malta, Montenegro, Portugal, Serbia, Slovenia, Spain, Vatican City
- Eastern Europe: Belarus, Bulgaria, Czech Republic, Hungary, Moldova, Poland
Our Products & Services
Sell · Finished Dosage Forms
Sell · Innovator APIs
Certifications
GMP
ISO
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment